ID Consult

Young children with neuromuscular disease are vulnerable to respiratory viruses

Publish date: May 15, 2019

 

References

1. Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002297.

2. “Advances in RSV Vaccine Research and Development – A Global Agenda.”

3. J Pediatric Infect Dis Soc. 2015 Dec;4(4): e143-6.

4. J Virol. 2015 Oct;89(20):10319-32.

5. Vaccine. 2017 Dec 18;35(51):7139-46.

Pages

Recommended Reading

Zero HIV transmission rate when viral load suppressed
Clinician Reviews
Rotavirus vaccine had strong protective effect in routine U.K. practice
Clinician Reviews
No exudates or fever? Age over 11? Skip strep test
Clinician Reviews
U.S. measles cases climb to over 800 for the year
Clinician Reviews
Flu vaccine visits reveal missed opportunities for HPV vaccination
Clinician Reviews
Part 2: Why the Increase?
Clinician Reviews
Infections within first year of life predicted IBD
Clinician Reviews
Is it measles? – Diagnosis and management for the pediatric provider
Clinician Reviews
Maternal immunization protects against serious RSV infection in infancy
Clinician Reviews
Measles complications in the U.S. unchanged in posteradication era
Clinician Reviews